|
 |
|
Global Hepatitis Diagnostics Market: Growth Opportunities and Business Expansion Strategies
This 320-page report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan.�Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed....
|
 |
|
$8750.00 |
| |
|
|
|
Sexually-Transmitted Diseases (STD): Global Market Outlook and Emerging Opportunities
This report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis....
|
|
|
$8500.00 |
| |
|
|
|
Analysis of the Respiratory Disease Testing Market in Europe:
Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
This new 335-page report from Venture Planning Group provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.About this Report This report presents detailed analysis of the Respiratory Disease market in Europe (France, Germany, Italy, Spain, UK)....
|
|
|
$8300.00 |
| |
|
|
|
Infectious Disease Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations
“Infectious Disease Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years.
|
|
|
$8200.00 |
| |
|
|
|
Enteric Diseases: Global Market Outlook and Emerging Opportunities
This report presents detailed analysis of the Enteric Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E....
|
|
|
$8000.00 |
| |
|
|
|
Analysis of the Sexually-Transmitted Disease Testing Market in Europe: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis
This new 318-page report from Venture Planning Group provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.The report presents detailed analysis of the STD market in Europe (France, Germany, Italy, Spain, UK), Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, and Syphilis. The report provides test volume and sales forecasts by country and market segment, including:
|
|
|
$7900.00 |
| |
|
|
|
Infectious Diseases in Europe: Market Segment Forecasts and Supplier Shares
This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive European survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies....
|
|
|
$7500.00 |
| |
|
|
|
Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
|
|
|
$6900.00 |
| |
|
|
|
Hepatitis A, B, C, D, E Diagnostics Market: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
|
|
|
$6900.00 |
| |
|
|
|
Analysis of the US Hospital Infectious Disease
Testing Market
This new report from Venture Planning Group contains 997 pages, 87 tables, and presents a comprehensive analysis of the US hospital infectious disease testing market, including:
|
|
|
$6800.00 |
| |
|
|
|
US Sales and Market Shares of Major Infectious Disease Testing Product Suppliers by Assay and Country
This unique report from Venture Planning Group provides US sales and market share estimates for major suppliers of infectious disease testing products by assay and country.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$6500.00 |
| |
|
|
|
Analysis of the Japanese Hospital Infectious Disease
Testing Market
This new report from Venture Planning Group contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including:
|
|
|
$5800.00 |
| |
|
|
|
The HIV/AIDS Diagnostics Market: US, Europe, Japan
Test Volumes, Sales Forecasts, and Supplier Shares by Country
This 7-country report presents detailed analyses of the AIDS diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. For each country, the report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments:
|
|
|
$4850.00 |
| |
|
|
|
Innovative CMV Diagnostic Technologies and Emerging Markets
The report contains 231 pages, 15 tables and presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$4850.00 |
| |
|
|
|
Innovative Herpes Diagnostic Technologies and Emerging Markets
The report contains 241 pages, 22 tables and presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Herpes definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for Herpes Simplex I/II and Herpes Type VI testing for the following markets:
|
|
|
$4850.00 |
| |
|
|
|
France Sales and Market Shares of Major Infectious Disease Testing Product Suppliers by Assay and Country
This unique report from Venture Planning Group provides France sales and market share estimates for major suppliers of infectious disease testing products by assay and country.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$4850.00 |
| |
|
|
|
Japan Sales and Market Shares of Major Infectious Disease Testing Product Suppliers by Assay and Country
This unique report from Venture Planning Group provides Japan sales and market share estimates for major suppliers of infectious disease testing products by assay and country.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$4750.00 |
| |
|
|
|
Germany Sales and Market Shares of Major Infectious Disease Testing Product Suppliers by Assay and Country
This unique report from Venture Planning Group provides Germany sales and market share estimates for major suppliers of infectious disease testing products by assay and country.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$4650.00 |
| |
|
|
|
|